Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Stabilized plasmid-lipid particles

Figure 6 Encapsulation of plasmid DNA (pDNA) in small sterically stabilized liposomes [stabilized plasmid-lipid particles (SPLP)] using a detergent dialysis procedure. (A) Entrapped pDNA-to-lipid ratio as a function of the initial pDNA-to-lipid ratio (mg/mg). The initial lipid concentration was lOmg/mL. (B) Cryo-electron micrograph showing the structure of SPLP. The location of the plasmid is indicated by the striated pattern superimposed on the liposomes. The bar represents 100 nm. Figure 6 Encapsulation of plasmid DNA (pDNA) in small sterically stabilized liposomes [stabilized plasmid-lipid particles (SPLP)] using a detergent dialysis procedure. (A) Entrapped pDNA-to-lipid ratio as a function of the initial pDNA-to-lipid ratio (mg/mg). The initial lipid concentration was lOmg/mL. (B) Cryo-electron micrograph showing the structure of SPLP. The location of the plasmid is indicated by the striated pattern superimposed on the liposomes. The bar represents 100 nm.
Figure 7 Pharmacokinetic properties and in vivo gene expression of stabilized plasmid-lipid particles (SPLP). (A) The levels of intact plasmid DNA (pDNA) in the circulation resulting from IV injection of naked plamid pDNA ( ), lipoplexes (O), and SPLP ( ) were determined by Southern blot analysis of plasma samples (100 pg pDNA/mouse). (B) Transgene expression at a distal tumor site resulting from rv injection of naked plamid pDNA ( ), plamid pDNA-cationic liposome complexes (O), and SPLP ( ). Figure 7 Pharmacokinetic properties and in vivo gene expression of stabilized plasmid-lipid particles (SPLP). (A) The levels of intact plasmid DNA (pDNA) in the circulation resulting from IV injection of naked plamid pDNA ( ), lipoplexes (O), and SPLP ( ) were determined by Southern blot analysis of plasma samples (100 pg pDNA/mouse). (B) Transgene expression at a distal tumor site resulting from rv injection of naked plamid pDNA ( ), plamid pDNA-cationic liposome complexes (O), and SPLP ( ).
Tam P, Monck M, Lee D, et al. Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther 2000 7 1867. [Pg.146]

Saravolac EG, Ludkovski O, Skirrow R, et al. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J Drug Target 2000 7 423. [Pg.146]

Fenske DB, MacLachlan I, Cullis PR. Stabilized plasmid-lipid particles a systemic gene therapy vector. In Phillips MI, ed. Methods in Enzymology Gene Therapy Methods. Vol. 346. San Diego, CA, U.S.A. Academic Press Inc., 2002 36-71. [Pg.146]

Mok KW, Lam AM, Cullis PR. Stabilized plasmid-lipid particles factors influencing plasmid entrapment and transfection properties. Biochim Biophys Acta 1999 1419 137. [Pg.147]

Monck, M.A., Mori, A., Lee, D., et al. (2000). Stabilized plasmid-lipid particles Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J. Dnug Tanget, 7, 439 152. [Pg.374]

Wheeler, J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R., Zhang, Y. et al. (1999) Stabilized plasmid-lipid particles construction and characterization. Gene Ther., 6, 271-281. [Pg.205]


See other pages where Stabilized plasmid-lipid particles is mentioned: [Pg.132]    [Pg.100]    [Pg.132]    [Pg.100]    [Pg.282]    [Pg.274]    [Pg.295]    [Pg.352]    [Pg.1531]    [Pg.674]   
See also in sourсe #XX -- [ Pg.100 ]




SEARCH



Lipid particles

Lipidic particles

Particles, stability

Stabilization particles

© 2024 chempedia.info